| 2026-04-30 |
详情>>
业绩披露：
2025年年报每股收益-1.16美元,归母净利润-7501.8万美元,同比去年增长-40.18%
|
| 2026-04-20 |
财报披露：
美东时间 2026-04-20 盘前发布财报
|
| 2026-03-18 |
详情>>
内部人交易：
Daniel Ran股份增加39474.00股
|
| 2026-03-13 |
详情>>
股本变动：
变动后总股本6959.02万股
|
| 2025-11-20 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.65美元,归母净利润-4164.5万美元,同比去年增长-5.55%
|
| 2025-11-17 |
股东大会：
将于2025-12-22召开股东大会
会议内容 ▼▲
- 1.To re-elect each of Erez Alroy and Noga Kainan as Class II directors, to serve until the Company’s annual general meeting of shareholders in 2028, and until their respective successors are duly elected and qualified;
2.To approve the re-appointment of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accountants for the fiscal year ending December 31, 2025, and for such additional period until our next annual general meeting.
|
| 2025-08-12 |
详情>>
业绩披露：
2025年中报每股收益-0.44美元,归母净利润-2796.1万美元,同比去年增长-8.31%
|
| 2025-05-22 |
详情>>
业绩披露：
2025年一季报每股收益-0.21美元,归母净利润-1323.9万美元,同比去年增长-8.15%
|
| 2025-04-09 |
详情>>
业绩披露：
2022年年报每股收益-2.17美元,归母净利润-1.13亿美元,同比去年增长-83.25%
|
| 2025-04-09 |
详情>>
业绩披露：
2024年年报每股收益-0.91美元,归母净利润-5351.6万美元,同比去年增长11.95%
|
| 2024-12-03 |
股东大会：
将于2024-12-03召开股东大会
会议内容 ▼▲
- 1.To re-elect each of Erez Meltzer and Nehama Ronen as Class I directors, to serve until the Company’s annual general meeting of shareholders in 2027, and until their respective successors are duly elected and qualified.
2.To approve the equity-based compensation terms of the non-executive directors who shall serve in such capacity immediately following the Meeting;
3.To approve the re-appointment of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accountants for the fiscal year ending December 31, 2024, and for such additional period until our next annual general meeting.
|
| 2024-12-03 |
股东大会：
将于2024-12-10召开股东大会
会议内容 ▼▲
- 1.To re-elect each of Erez Meltzer and Nehama Ronen as Class I directors, to serve until the Company’s annual general meeting of shareholders in 2027, and until their respective successors are duly elected and qualified.
2.To approve the equity-based compensation terms of the non-executive directors who shall serve in such capacity immediately following the Meeting;
3.To approve the re-appointment of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accountants for the fiscal year ending December 31, 2024, and for such additional period until our next annual general meeting.
|
| 2024-11-21 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.68美元,归母净利润-3945.5万美元,同比去年增长21.91%
|
| 2024-08-20 |
详情>>
业绩披露：
2024年中报每股收益-0.45美元,归母净利润-2581.6万美元,同比去年增长11.36%
|
| 2024-06-18 |
股东大会：
将于2024-06-25召开股东大会
会议内容 ▼▲
- (1)To approve Company’s Compensation Policy for Directors and Officers.
(2)To nominate Mr. Erez Meltzer as the Acting Chairman of the Board.
(3)To approve an equity grant to Mr. Erez Meltzer in his capacity as the Chief Executive Officer of the Company.
(4)To approve a cash compensation scheme to the non-employee directors of the Company.
|
| 2024-05-28 |
详情>>
业绩披露：
2024年一季报每股收益-0.21美元,归母净利润-1224.1万美元,同比去年增长-4.08%
|
| 2024-05-08 |
股东大会：
将于2024-06-18召开股东大会
会议内容 ▼▲
- (1)To approve Company’s Compensation Policy for Directors and Officers.
(2)To nominate Mr. Erez Meltzer as the Acting Chairman of the Board.
(3)To approve an equity grant to Mr. Erez Meltzer in his capacity as the Chief Executive Officer of the Company.
(4)To approve a cash compensation scheme to the non-employee directors of the Company.
|
| 2024-04-22 |
详情>>
业绩披露：
2023年年报每股收益-1.08美元,归母净利润-6077.6万美元,同比去年增长46.33%
|
| 2024-02-15 |
复牌提示：
2024-02-15 09:38:27 停牌，复牌日期 2024-02-15 09:43:27
|
| 2023-12-27 |
股东大会：
将于2023-12-31召开股东大会
会议内容 ▼▲
- 1.To (i) re-elect each of Ran Poliakine, Dan Suesskind and So Young Shin as Class III directors, to serve until the Company’s annual general meeting of shareholders in 2026, and until their respective successors are duly elected and qualified and (ii) elect Nehama Ronen as a Class I director for a one-year term to expire at the 2024 annual general meeting of shareholders, and until her successor is duly elected and qualified;
2.To approve the award of options to the non-executive directors who shall serve in such capacity immediately following the Meeting;
3.To approve the re-appointment of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accountants for the fiscal year ending December 31, 2023, and for such additional period until our next annual general meeting.
|
| 2023-11-16 |
股东大会：
将于2023-12-27召开股东大会
会议内容 ▼▲
- 1.To (i) re-elect each of Ran Poliakine, Dan Suesskind and So Young Shin as Class III directors, to serve until the Company’s annual general meeting of shareholders in 2026, and until their respective successors are duly elected and qualified and (ii) elect Nehama Ronen as a Class I director for a one-year term to expire at the 2024 annual general meeting of shareholders, and until her successor is duly elected and qualified;
2.To approve the award of options to the non-executive directors who shall serve in such capacity immediately following the Meeting;
3.To approve the re-appointment of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accountants for the fiscal year ending December 31, 2023, and for such additional period until our next annual general meeting.
|
| 2022-11-10 |
股东大会：
将于2022-12-21召开股东大会
会议内容 ▼▲
- 1.To re-elect each of Erez Alroy and Noga Kainan as Class II directors, to serve until the Company’s annual general meeting of shareholders in 2025, and until their respective successors are duly elected and qualified.
2.To approve the award of options to the non-executive directors Erez Alroy, Noga Kainan and Dan Suesskind, provided that in the case of Erez Alroy and Noga Kainan, subject to their respective election as directors at the Meeting under Proposal 1.
3.To approve the compensation of Mr. Ran Poliakine as non-executive Chairman of the Board of Directors.
4.To approve the re-appointment of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accountants for the fiscal year ending December 31, 2022 and for such additional period until our next annual general meeting.
|
| 2021-09-30 |
股东大会：
将于2021-11-04召开股东大会
会议内容 ▼▲
- 1.To approve the re-appointment of Kesselman & Kesselman (PwC Israel) as the Company’s independent auditors for the year ending December 31, 2021 and for such additional period until the next annual general meeting of the Company’s shareholders;
2.To approve the re-appointment of Mr. Erez Meltzer and Prof. Richard Stone as the Class I members of the Board;
3.To approve the terms of engagement of Mr. Erez Meltzer as the Company’s new Chief Executive Officer;
4.To review the Auditor’s Report and the Company’s Consolidated Financial Statements for the fiscal year ended December 31, 2020.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-12-31 |
股东大会：
将于2021-02-09召开股东大会
会议内容 ▼▲
- 1.To approve of the Company’s Compensation Policy for Executive Officers and Directors, adopted by the Board of Directors on December 24, 2020 (the “Compensation Policy”), required in accordance with the Israeli Companies Law 5759-1999 (the “Companies Law”);
2.To approve of the Company’s Equity Compensation Plan for Executive Officers and Directors, adopted by the Board of Directors on December 24, 2020 (the “Equity Compensation Plan”), required in accordance with regulations under the Companies Law;
3.To approve additional cash compensation for directors who serve on committees of the Company’s Board of Directors in accordance with the Compensation Policy;
4.To approve the appointment of Mr. Dan Suesskind and Mrs. Noga Kainan as “External Directors” of the Company (as such term is defined in the Companies Law) and to approve their compensation;
5.To approve the amendment to the employment agreement of Mr. Ran Poliakine, the CEO and Chairman of the Company, regarding his cash bonus entitlement;
6.To approve additional compensation to Dr. Floyd Katske for services provided to the Company that are not connected to his duties as a director in accordance with the Compensation Policy;
7.To approve Mr. Erez Melzer as a Designated Director pursuant to the Compensation Policy and to approve his additional compensation in such capacity.
|